default author photo

Christian F. Ockenhouse

affiliation not provided to SSRN

SCHOLARLY PAPERS

1

DOWNLOADS

74

TOTAL CITATIONS

2

Scholarly Papers (1)

1.

Safety, Tolerability and Plasmodium Falciparum Transmission-Reducing Activity of Monoclonal Antibody TB31F: An Open-Label, First-in-Human, Trial in Healthy Malaria-Naïve Adults

Number of pages: 20 Posted: 10 Mar 2022
Radboud University Nijmegen - Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Nijmegen - Department of Medical Microbiology, Radboud University Nijmegen - Radboud University Medical Center, Radboud University Nijmegen - Radboud Institute for Health Sciences, Radboud University Nijmegen - Department of Medical Microbiology, Radboud University Nijmegen - Department of Medical Microbiology, Radboud University Nijmegen - Department of Medical Microbiology, Radboud University Nijmegen - Radboud University Medical Center, affiliation not provided to SSRN, PATH, PATH's Malaria Vaccine Initiative, affiliation not provided to SSRN, affiliation not provided to SSRN, Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Imperial College London, TropIQ Health Sciences, Radboud University Nijmegen - Department of Pharmacy and Radboud Center for Infectious Diseases, affiliation not provided to SSRN, affiliation not provided to SSRN, Radboud University Nijmegen - Department of Medical Microbiology and Radboud University Nijmegen - Department of Medical Microbiology
Downloads 74 (844,901)
Citation 2

Abstract:

Loading...

Malaria, Plasmodium falciparum, monoclonal antibody, transmission-reducing, transmission-blocking, TB31F